Prescription Recalls

STAT (2/23, Silverman) reports that a new analysis published in Pharmacoepidemiology and Drug Safety concludes that drug-makers “generally fail to include key data that the FDA might use to assess future warnings” in their...

As a result of the drug makers failure to adequately warn about the risks associated with the anticoagulant, financial compensation may be available through a Xarelto lawsuit for individuals who have experienced: Internal Bleeding or...

Pharmaceutical giant Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its blockbuster anti-cholesterol drug Lipitor but never properly warned the...

Blood level monitoring and dose adjustment for dabigatran (Pradaxa) could reduce major bleeding risk by as much as 20% compared with unadjusted use, according to company analyses allegedly hidden from physicians and regulators. An investigation...

Takeda Pharmaceutical Co Ltd said it would contest $6 billion in punitive damages imposed by a jury in the United States in a case that accused Japan's largest drug maker of concealing cancer risks...

The U.S. Food and Drug Administration (FDA) is advising the public that it is evaluating studies showing that prescription testosterone products might cause stroke, heart attacks, and death in men who use them. What Are...

In early 2012, analysis of clinical trial results prompted the U.S. Food and Drug Administration (FDA) to change the labels of the cholesterol-reducing drug Lipitor to state that it increases a user’s risk of...